Safety, Tolerability, and Pharmacokinetics of Single Dose TenoMiR as a Treatment for Tennis Elbow
Status:
Completed
Trial end date:
2021-08-18
Target enrollment:
Participant gender:
Summary
This study is testing a drug called TenoMiR that is being developed for the treatment of
tennis elbow (lateral epicondylitis). The study drug is a new compound that works by
improving the quality of the collagen which helps repair damage to the elbow. The study drug
is being developed in the hope of providing a more reliable treatment than those currently
available and can be given at the time of first diagnosis, so that recovery can begin as soon
as possible.